Medicare Enrolled

Dr. Wafa Musa Popeney, D.O.

Family Medicine · Sugar Land, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2655 CORDES DR STE 110, Sugar Land, TX 77479
2819803311
In practice since 2006 (19 years)
NPI: 1487670543 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Musa Popeney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Musa Popeney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Musa Popeney

Dr. Wafa Musa Popeney is a family medicine specialist in Sugar Land, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Musa Popeney performed 404 Medicare services across 266 unique beneficiaries.

Between the years covered by Open Payments, Dr. Musa Popeney received a total of $7,011 from 67 pharmaceutical and/or device companies across 339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Musa Popeney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 404 Medicare services $7,011 industry payments

Medicare Practice Summary

Medicare Utilization ↗
404
Medicare services
Bottom 46% in TX for family medicine
266
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min) 212 $49 $110
Office visit, established patient (30-39 min) 135 $85 $141
Annual wellness visit, follow-up 46 $117 $150
New patient office visit (45-59 min) 11 $110 $193
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,011
Total received (2018-2024)
Avg $1,002/year across 7 years
Top 9% in TX for family medicine
67
Companies
339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,623 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$389 (5.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,668
2023
$1,106
2022
$1,055
2021
$534
2020
$349
2019
$1,010
2018
$1,290

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,113
UCB, Inc.
$433
ACADIA Pharmaceuticals Inc
$382
Grifols USA, LLC
$363
Teva Pharmaceuticals USA, Inc.
$344
Lilly USA, LLC
$328
GENZYME CORPORATION
$286
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$275
AstraZeneca Pharmaceuticals LP
$237
Allergan, Inc.
$207
Vanda Pharmaceuticals Inc.
$201
Amgen Inc.
$161
Bausch Health US, LLC
$139
Avanir Pharmaceuticals, Inc.
$135
EMD Serono, Inc.
$129
Lundbeck LLC
$124
Duchesnay USA Incorporated
$119
Promius Pharma LLC
$111
CSL Behring
$104
ARGENX US, INC.
$104
Harmony Biosciences LLC
$90
ARBOR PHARMACEUTICALS, INC.
$89
Abbott Laboratories
$86
Otsuka America Pharmaceutical, Inc.
$83
Genentech USA, Inc.
$68
Eisai Inc.
$67
Upsher-Smith Laboratories LLC
$67
Novartis Pharmaceuticals Corporation
$66
Biogen, Inc.
$63
AbbVie Inc.
$61
Novo Nordisk Inc
$55
Endo Pharmaceuticals Inc.
$53
Scilex Pharmaceuticals Inc.
$50
Merck Sharp & Dohme Corporation
$48
Takeda Pharmaceuticals U.S.A., Inc.
$44
Zyla Life Sciences
$43
HARMONY BIOSCIENCES LLC
$41
AQUESTIVE THERAPEUTICS, INC.
$40
Neurelis, Inc.
$38
Impax Laboratories, Inc.
$36
SCILEX PHARMACEUTICALS INC.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$31
Hologic Sales and Service, LLC
$29
Merz North America, Inc.
$28
Supernus Pharmaceuticals, Inc.
$24
Merz Pharmaceuticals, LLC
$23
Regeneron Healthcare Solutions, Inc.
$22
Madrigal Pharmaceuticals
$20
Vertical Pharmaceuticals, LLC
$20
Celgene Corporation
$20
SK Life Science, Inc.
$19
INTERCEPT PHARMACEUTICALS, INC.
$19
Avion Pharmaceuticals
$19
Mylan Pharmaceuticals Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Biohaven Pharmaceuticals, Inc.
$18
Neurocrine Biosciences, Inc.
$18
Ironwood Pharmaceuticals, Inc
$17
UPSHER-SMITH LABORATORIES LLC
$17
Amarin Pharma Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
IRONWOOD PHARMACEUTICALS, INC
$15
Mallinckrodt LLC
$15
Arbor Pharmaceuticals, Inc.
$14
Astellas Pharma US Inc
$14
Medtronic MiniMed, Inc.
$12
Allergan Inc.
$12
Top 3 companies account for 27.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · AUBAGIO · Aimovig · BOTOX · BYDUREON · Briviact · CREON · DUPIXENT · Dhivy · EMGALITY · Evrysdi · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · Fintepla · GILENYA · Gamunex-C · Glatiramer Acetate · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · JANUVIA · JARDIANCE · LEMTRADA · LINZESS · LORZONE · Leqembi · Linzess · MAYZENT · MIGRANAL · MYRBETRIQ · Mavenclad · NASCOBAL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCALIVA · Osphena · Ozempic · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RESMETIROM · REXULTI · Rystiggo · SPINRAZA · SPRIX · SYMBICORT · SYMPAZAN · Saxenda · THINPREP 2000 PROCESSOR · TOSYMRA · TOUJEO · TROKENDI XR · TRULANCE · TRULICITY · UBRELVY · ULTOMIRIS · VALTOCO · VIBERZI · VIIBRYD · VRAYLAR · VYEPTI · VYVGART · Vascepa · WAKIX · Wakix · XCOPRI · XEOMIN · XIFAXAN · Xembify · ZEPOSIA · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in TX.

Equivalent to $1,736 per 100 Medicare services performed
Looking for a family medicine specialist in Sugar Land?
Compare family medicine physicians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,306
Per 100K population
151.9
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Musa Popeney is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Musa Popeney experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Musa Popeney performed 212 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Musa Popeney receive payments from pharmaceutical companies?
Yes. Dr. Musa Popeney received a total of $7,011 from 67 companies across 339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Musa Popeney's costs compare to other family medicine physicians in Sugar Land?
Dr. Musa Popeney's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Musa Popeney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →